Cargando…
Analysis of CD74 Occurrence in Oncogenic Fusion Proteins
CD74 is a type II cell surface receptor found to be highly expressed in several hematological and solid cancers, due to its ability to activate pathways associated with tumor cell survival and proliferation. Over the past 16 years, CD74 has emerged as a commonly detected fusion partner in multiple o...
Autores principales: | Vargas, Jasmine, Pantouris, Georgios |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10650716/ https://www.ncbi.nlm.nih.gov/pubmed/37958963 http://dx.doi.org/10.3390/ijms242115981 |
Ejemplares similares
-
CD74-NRG1 Fusions Are Oncogenic In Vivo and Induce Therapeutically Tractable ERBB2:ERBB3 Heterodimerization
por: Werr, Lisa, et al.
Publicado: (2022) -
CD74 in Kidney Disease
por: Valiño-Rivas, Lara, et al.
Publicado: (2015) -
The role of CD74 in cardiovascular disease
por: Li, Qiu-Lin, et al.
Publicado: (2023) -
A Pan-Cancer Analysis of the Oncogenic Role of WD Repeat Domain 74 in Multiple Tumors
por: Wu, Xiaoxuan, et al.
Publicado: (2022) -
Protocol for purification and enzymatic characterization of members of the human macrophage migration inhibitory factor superfamily
por: Parkins, Andrew, et al.
Publicado: (2023)